Radiotherapy and immunotherapy combinations in non-small cell lung cancer: a promising future?
Affiliation
Centre for Cancer Research and Cell Biology, Queen's University of Belfast, BelfastIssue Date
2016-08-09
Metadata
Show full item recordAbstract
The goal of re-programming the host immune system to target malignancy with durable anti-tumour clinical responses has been speculated for decades. In the last decade such speculation has been transformed into reality with unprecedented and durable responses to immune checkpoint inhibitors seen in solid tumours. This mini-review considers the mechanism of action of immune modulating agents and the potential for combination with radiotherapy in the treatment of non-small cell lung cancer.Citation
Radiotherapy and immunotherapy combinations in non-small cell lung cancer: a promising future? 2016: Clin OncolJournal
Clinical OncologyDOI
10.1016/j.clon.2016.07.014PubMed ID
27519157Type
ArticleLanguage
enISSN
1433-2981ae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2016.07.014